|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.8 NOK | -5.03% |
|
+0.53% | -8.92% |
| Apr. 29 | Gentian Diagnostics Asa Resolves to Elect Ms. Hilja Ibert as Chairperson of the Board of Directors | CI |
| Apr. 29 | Gentian Diagnostics ASA Appoints Mr. Njaal Kind as Acting CEO | CI |
Gentian Diagnostics ASA reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was NOK 31.44 million compared to NOK 20.56 million a year ago. Revenue was NOK 33.6 million compared to NOK 23.09 million a year ago.
Net loss was NOK 0.657 million compared to NOK 6.63 million a year ago. Basic loss per share from continuing operations was NOK 0.043 compared to NOK 0.43 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -8.92% | 55.83M | |
| +1.09% | 12.95B | |
| -7.57% | 7.84B | |
| +2.77% | 5.5B | |
| +0.93% | 4.61B | |
| +8.48% | 4.61B | |
| -49.25% | 3.4B | |
| +9.21% | 2.66B | |
| -14.07% | 2.08B | |
| +3.45% | 1.79B |
GENTIAN DIAGNOSTICS 
